BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 30418592)

  • 1. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.
    Grommes C; Rubenstein JL; DeAngelis LM; Ferreri AJM; Batchelor TT
    Neuro Oncol; 2019 Feb; 21(3):296-305. PubMed ID: 30418592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Central Nervous System Lymphomas of the Brain: A Retrospective Analysis in a Single Institution.
    Lin TK; Yeh TH; Hsu PW; Chuang CC; Tu PH; Chen PY; Jung SM; Wei KC; Huang YC
    World Neurosurg; 2017 Jul; 103():550-556. PubMed ID: 28363832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Nervous System Lymphoma.
    Chukwueke UN; Nayak L
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):597-611. PubMed ID: 31229157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
    Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the treatment of primary central nervous system lymphoma in a Regional Cancer Center of South India: Impact of high-dose methotrexate on treatment outcome.
    Rudresha AH; Chaudhuri T; Lakshmaiah KC; Babu G; Lokesh KN; Rajeev LK
    J Cancer Res Ther; 2020; 16(1):13-17. PubMed ID: 32362603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity.
    Song KW; Batchelor T
    Curr Oncol Rep; 2021 Sep; 23(11):132. PubMed ID: 34524547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies.
    Sethi TK; Reddy NM
    Leuk Lymphoma; 2019 Jan; 60(1):6-18. PubMed ID: 29741421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary CNS Lymphoma.
    Grommes C; DeAngelis LM
    J Clin Oncol; 2017 Jul; 35(21):2410-2418. PubMed ID: 28640701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Central Nervous System Lymphoma in an Immunocompetent Patient Presenting as Multiple Cerebellar Lesions: A Case Report and Review of Literature.
    Galarza Fortuna GM; Dvir K; Febres-Aldana C; Schwartz M; Medina AM
    J Investig Med High Impact Case Rep; 2019; 7():2324709619893548. PubMed ID: 31818145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
    Zhao D; Qian L; Shen J; Liu X; Mei K; Cen J; Wang Y; Li C; Ma Y
    J Cell Mol Med; 2014 Jun; 18(6):1081-6. PubMed ID: 24628986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy.
    Biswas A; Adhikari N; Bakhshi S; Gopinathan VR; Sharma MC
    Pediatr Neurosurg; 2019; 54(1):57-65. PubMed ID: 30669145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of primary central nervous system lymphoma.
    Ekenel M; DeAngelis LM
    Curr Neurol Neurosci Rep; 2007 May; 7(3):191-9. PubMed ID: 17488584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study.
    Fleury I; Amorim S; Mounier N; Coiffier B; Dupuis J; Tilly H; Mazari MA; Filliatre L; Brière J; Brice P; de Kerviler E; Thieblemont C
    Leuk Lymphoma; 2015 Jul; 56(7):2025-31. PubMed ID: 25347431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches in primary central nervous system lymphoma.
    Fraser E; Gruenberg K; Rubenstein JL
    Chin Clin Oncol; 2015 Mar; 4(1):11. PubMed ID: 25841718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 Activation Is Associated with Interleukin-10 Expression and Survival in Primary Central Nervous System Lymphoma.
    Yang X; Wang Y; Sun X; Bai X; Cui Q; Zhu H; Qian J; Chen Y; Sun S; Ji N; Liu Y
    World Neurosurg; 2020 Feb; 134():e1077-e1084. PubMed ID: 31778838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.